Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.57B | $2.74B | $3.00B | $3.52B | $3.71B | $4.02B | $4.37B | $4.48B | $4.77B | $5.08B |
| Revenue growth | — | 6.5% | 9.6% | 17.3% | 5.4% | 8.4% | 8.7% | 2.4% | 6.5% | 6.6% |
| Gross profit | $1.02B | $1.06B | $1.08B | $1.23B | $1.29B | $1.43B | $1.54B | $1.57B | $1.69B | $1.83B |
| Gross margin | 39.5% | 38.6% | 36.0% | 34.8% | 34.8% | 35.6% | 35.1% | 35.1% | 35.5% | 36.0% |
| Operating income | $341M | $331M | $348M | $429M | $439M | $509M | $502M | $631M | $702M | $750M |
| Operating margin | 13.3% | 12.1% | 11.6% | 12.2% | 11.8% | 12.7% | 11.5% | 14.1% | 14.7% | 14.8% |
| Net income | $270M | $263M | $282M | $305M | $308M | $369M | $353M | $631M | $514M | $552M |
| Net margin | 10.5% | 9.6% | 9.4% | 8.7% | 8.3% | 9.2% | 8.1% | 14.1% | 10.8% | 10.9% |
| EPS (diluted) | $1.28 | $1.34 | $1.45 | $1.56 | $1.57 | $1.91 | $1.88 | $3.41 | $2.85 | $3.13 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $346M | $359M | $340M | $428M | $584M | $694M | $444M | $491M | $615M | $813M |
| Capital expenditures | $81.9M | $57.2M | $85.0M | $74.9M | $70.2M | $53.3M | $50.6M | $55.4M | $82.8M | $78.2M |
| Free cash flow | $264M | $302M | $255M | $353M | $514M | $641M | $393M | $435M | $533M | $735M |
| Share buybacks | $345M | $220M | $154M | $30.0M | $137M | $298M | $214M | $225M | $253M | — |
| Dividends paid | — | $46.7M | $57.1M | $64.7M | $74.2M | $80.5M | $91.8M | $100M | $108M | $118M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $423M | $504M | $368M | $467M | $680M | $899M | $647M | $584M | $648M | $854M |
| Total assets | $2.89B | $3.45B | $3.53B | $4.45B | $4.87B | $4.98B | $4.59B | $4.81B | $4.99B | $5.84B |
| Total liabilities | $1.59B | $2.02B | $2.13B | $2.77B | $3.04B | $3.08B | $2.76B | $2.56B | $2.60B | $3.29B |
| Long-term debt | $698M | $1.01B | $976M | $1.34B | $1.31B | $1.27B | $1.25B | $825M | $1.20B | $1.17B |
| Shareholders' equity | $1.29B | $1.42B | $1.40B | $1.69B | $1.83B | $1.90B | $1.83B | $2.25B | $2.39B | $2.55B |
| Retained earnings | $358M | $356M | $438M | $649M | $742M | $732M | $780M | $1.09B | $1.24B | $1.39B |
| Shares (wtd avg diluted) | 210M | 197M | 194M | 195M | 196M | 193M | 188M | 185M | 180M | 177M |
Every figure is extracted from Genpact LTD’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.